
World Cancer Day, observed annually on February 4, is a global initiative to raise awareness, improve education, and drive action towards a world where cancer care is equitable and accessible for all. As we mark World Cancer Day 2025, we reflect on the progress made, the challenges that remain, and the collective efforts required to reduce disparities in cancer outcomes.
At the heart of this mission is the Inequalities in Cancer Outcomes Network (ICON)—a research group dedicated to understanding and addressing the socioeconomic, regional, and systemic barriers contributing to cancer disparities. This year, we highlight some of ICON’s honorary members, whose insights shed light on key issues and the path forward.

Breaking barriers: ensuring access to awareness and quality care
Dr Aurelien Belot, an Honorary Associate Professor in Medical Statistics with ICON, emphasises the importance of reaching marginalised communities with cancer awareness and quality care.
He said: “The first step in improving cancer awareness is to make educational programs more accessible by creating culturally sensitive materials in multiple languages. Collaborating with trusted local organizations, launching mobile health campaigns, and utilising social media can further enhance outreach and impact.”
Early detection remains critical, particularly for marginalised groups, and Aurelien highlights the need to reduce stigma and misconceptions about cancer.
He added: “Building peer-support networks, training community health workers, and improving access to treatment through better transportation are all crucial steps in bridging the gap between communities and healthcare.
“Cancer is not a single disease but a collection of many different cancers, each requiring tailored interventions. Addressing disparities means ensuring that prevention, screening, and treatment reach those who need them most.”
The role of research and funding in driving change
Securing research funding has always been a challenge, but Dr Laura Woods, Senior Public Health lecturer at Newcastle University and ICON honorary member notes how the landscape has evolved.

She said: “Stronger collaboration, higher standards, and meaningful patient engagement are driving better cancer research and outcomes.
“There’s also a stronger emphasis on engaging patients, carers, and the public, which has been highly beneficial. Additionally, stricter data access regulations ensure the ethical and effective use of information. While these factors make proposal writing more time-consuming and uncertain, they have fostered stronger collaboration.”
Despite these challenges, Laura highlights a silver lining: the need for stronger teamwork and collaboration. “Having access to ICON’s broad network of experts has strengthened applications, leading to higher-quality research proposals and ultimately better outcomes for patients.”
On a personal level, Laura values her collaboration with ICON not just professionally but as a meaningful connection with colleagues. “I’ve worked with ICON members for over two decades, and it’s always a privilege to be part of their work and witness their impact.”
Understanding cancer disparities: A lifelong commitment

For Dr Miguel Angel Luque-Fernandez, a cancer epidemiologist, the rising burden of cancer in an aging world motivated him to study the disease.
He said: “Cancer cases are projected to rise dramatically, placing a significant societal and economic burden. Prevention is key: 30-50% of cancer deaths could be avoided through early detection and intervention.”
Miguel’s research uses advanced statistical and causal inference methods to understand the interplay between genetics, lifestyle, environment, and socioeconomic factors—an approach that aligns closely with ICON’s mission.
He added: “Cancer research must move beyond examining single risk factors in isolation and instead adopt a holistic perspective.”
Collaboration with ICON has been instrumental in his career, providing opportunities to work with leading experts, contribute to impactful publications, and develop interventions to reduce disparities. But beyond the science, what keeps him engaged with ICON?
“The welcoming, supportive, and friendly collaboration with ICON members makes me want to continue working with them forever.”
The power of collaboration: ICON’s honorary members

ICON’s impact is amplified by its honorary members—experts who have worked closely with the group for years. Professor Bernard Rachet, who leads the ICON project highlights their invaluable contributions.
He said: “Collaborating with our honorary staff members benefits both ICON and the School. Their expertise and dedication enhance our research, capacity building, and academic outputs. We are deeply grateful for their continued support and commitment to our shared goals.
“Progress in cancer research and equity thrives on collaboration, shared knowledge, and a united effort to leave no one behind.”
To mark World Cancer Day 2025, ICON, in collaboration with the Centre for Global Chronic Conditions and the Centre for History in Public Health at LSHTM, is co-hosting a screening of Burkitt. This documentary film explores the life and legacy of Irish surgeon Dr Denis Burkitt, who discovered Burkitt’s lymphoma, as told through the perspective of a survivor of this cancer. The screening will take place on 25 February at the Manson Lecture Theatre at LSHTM, Keppel Street followed by a Q&A with the filmmaker and guests.
